Lupin net up by 25% to Rs 140 cr in Q1

Lupin, the fifth largest pharmaceutical company India with consolidated net sales of Rs 3,776 crore, has posted satisfactory performance during the first quarter ended June 2009 and its net profit moved up by 25.1 per cent to Rs 140.11 crore from Rs 112.04 crore in the corresponding period of last year. The consolidated net sales also increased by 25.9 per cent to Rs 1086 crore from Rs 862 crore. With better profit level, its earnings per share worked out to Rs 16.91 as against Rs 13.65.

The company's profit before interest, depreciation and tax increased by 24.6 per cent to Rs 215.24 crore from Rs 172.80 crore in the similar period of last year. 


Popular posts from this blog

GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut

Trump wants more mental health care; Alabama says it's trying